CD300E

 

Full name: CD300e molecule Alias Symbol: IREM2|CLM2
Type: protein-coding gene Cytoband: 17q25.1
Entrez ID: 342510 HGNC ID: HGNC:28874 Ensembl Gene: ENSG00000186407 OMIM ID: 609801
Drug and gene relationship at DGIdb

 

Expression of CD300E:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE53622 CD300E 342510 45638 0.5797 0.0002
GSE53624 CD300E 342510 68511 1.2187 0.0000
GSE97050 CD300E 342510 A_33_P3358104 1.0610 0.1782
SRP064894 CD300E 342510 RNAseq 0.7452 0.1457
SRP133303 CD300E 342510 RNAseq 0.7571 0.0023
SRP159526 CD300E 342510 RNAseq 2.0230 0.0012
SRP193095 CD300E 342510 RNAseq 1.7136 0.0000
SRP219564 CD300E 342510 RNAseq 1.3664 0.0334
TCGA CD300E 342510 RNAseq 0.7091 0.3847

Upregulated datasets: 4; Downregulated datasets: 0.  


 

Survival by CD300E expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of CD300E:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 CD300E 342510 3 2 25
GSE20123 CD300E 342510 3 2 25
GSE43470 CD300E 342510 5 3 35
GSE46452 CD300E 342510 33 0 26
GSE47630 CD300E 342510 8 1 31
GSE54993 CD300E 342510 2 5 63
GSE54994 CD300E 342510 10 4 39
GSE60625 CD300E 342510 6 0 5
GSE74703 CD300E 342510 5 1 30
GSE74704 CD300E 342510 3 1 16
TCGA CD300E 342510 32 10 54

Total number of gains: 110; Total number of losses: 29; Total Number of normals: 349.  


 

Somatic mutations of CD300E:

 

Generating mutation plots.

 

Highly correlated genes for CD300E:

 

Showing all 19 correlated genes with mean PCC>0.5.

Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
CD300ECD300C0.700095303
CD300ESDS0.675487303
CD300EGPR40.668278303
CD300EFPR30.667648303
CD300ECOTL10.650339303
CD300ESNAI10.648355303
CD300ERIPK20.642237303
CD300ECCR10.640368303
CD300ERNASE20.637607303
CD300ELILRA50.631413403
CD300EHLX0.629051303
CD300EZBP10.621489303
CD300ECYP27B10.604825303
CD300EMEFV0.594329403
CD300EIL100.579474303
CD300ERELT0.562147303
CD300ESLC22A160.549951403
CD300EITGAX0.536183303
CD300EFKBP140.533881403

For details and further investigation, click here